The Past, Present and Future of Heart Transplantation
Korean Circulation Journal
;
: 565-590, 2018.
Article
in English
| WPRIM
| ID: wpr-759386
ABSTRACT
Heart transplantation (HTx) has become standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-HTx care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of HTx recipients. However, limitations to long-term allograft survival exist, including rejection, infection, coronary allograft vasculopathy, and malignancy. Careful balance of immunosuppressive therapy and vigilant surveillance for complications can further improve long-term outcomes of HTx recipients.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Tissue Donors
/
Heart Transplantation
/
Allografts
/
Forecasting
/
Heart
/
Heart Failure
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Korean Circulation Journal
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS